https://brivanibinhibitor.com/....results-of-n-acetyl-
RESULTS Of 504 patients waitlisted with T-LVADs, almost all were transplanted (50%), bridged to CF-LVAD (17%), or recovered (9%). An overall total of 9047 recipients had been bridged to OHT during the research duration with 8875 CF-LVADs and 172 T-LVADs. Early survival in propensity-matched T-LVAD ± T-RVAD patients ended up being similar to CF-LVAD ± T-RVAD customers but paid off at a 1-year followup. This difference in success at 1-year follow-up ended
Like
Comment
Share
